Home›Antineoplastic and Immunomodulating Agents›Mechanism of Action›InhibitorBrowse ByInhibitorFactsInhibitorSourcesComments (0)Reader Challenges (0)FactsComparisonATC Level 1 CodeWell-attestedSourced to the subject's own accountL - Antineoplastic and immunomodulating agents 1InhibitorFilter Results26 entriesATC ClassAllL: Antineoplastic and Immunomodulating Agents (26)S: Sensory Organs (1)Route of AdministrationAllIntravenous (10)Oral (15)Subcutaneous (2)Approval StatusAllApproved (25)Investigational / Clinical Trial (1)Era (First Approved)All1959 (1)1964 (1)1969 (1)1975 (1)1976 (1)1977 (1)1978 (1)1999 (1)2002 (1)2004 (1)2005 (1)2012 (1)2013 (1)2015 (2)2016 (1)2017 (1)2018 (2)2020 (3)2021 (1)2023 (1)2024 (2)WHO Essential MedicineAllComplementary List (6)Treats (Condition)AllArthritis (1)Cancer (1)COVID-19 (1)Giant cell arteritis (1)Hidradenitis Suppurativa (1)Psoriasis (1)Severe Acute Respiratory Syndrome (1)Uveitis (1)Wilms Tumor (1)Show ResultsBrowseCompareSelect all 26AdalimumabInhibitorBevacizumabInhibitorBinimetinibInhibitorBrigatinibInhibitorCarmustineInhibitorCisplatinInhibitorCobimetinibInhibitorCytarabineInhibitorDacarbazineInhibitorDactinomycinInhibitorDecitabine/cedazuridineInhibitorEncorafenibInhibitorFruquintinibInhibitorLomustineInhibitorPanobinostatInhibitorRadotinibInhibitorRipretinibInhibitorRucaparibInhibitorTemozolomideInhibitorThiotepaInhibitorTislelizumabInhibitorTivozanibInhibitorTocilizumabInhibitorTrametinibInhibitorTucatinibInhibitorVorasidenibInhibitorSources1. Anatomical Therapeutic Chemical Classification System (Wikipedia)tier 3WikipediaATC Level 1 codes table, group LQuote, ATC Level 1 codes table, group LL - "Antineoplastic and immunomodulating agents"View the SourceComments (0)No comments yet. Be the first to share a thought.Sign in to join the discussion.Reader Challenges (0)No disputes yet. Spotted an error or a better source? Open the first one.Sign in to dispute this or suggest a correction.